Experts have warned about antibiotic resistance

Recently, CDC is focusing all its resources on dealing with resistant bacteria. Experts believe that the war we face is still very difficult.

Can we finally turn the tide in the fight against drug-resistant bacteria? Officials at the CDC's Centers for Disease Control and Prevention seem to think the same.

CDC is introducing its research achievements across the United States through the presentation of their Innovative Antimicrobial Solutions Initiatives.

These initiatives are primarily about infrastructure support to help detect and prevent occurrences. These include laboratories that help diagnose, educate, and help prevent bacterial outbreaks. Local drug resistance.

Some of the highlights of the CDC initiative include the prevention of a rare enzyme secreted by bacteria, discovered in Kentucky, that could lead to the formation of resistant bacteria.

The agency is beginning a special test of a potentially dangerous , deadly multi-drug fungus called Candida auris .

The results were quite positive, showing improvement in local response and testing of resistant drug gonorrhea in California.

A nationwide activity map shows all CDC's efforts have been made in each state throughout the years.

Antibiotic resistance is a global problem.(Illustration).

Michael Craig, senior advisor on coordinating the fight against drug-resistant bacteria and strategy at CDC, said: "We are in a better position to fight drug-resistant strains of bacteria. CDC's efforts. in all 50 states of the country are showing very good results ".

"We are starting to turn things around, but we need to maintain their progress. It takes strong and drastic actions to win this war."

The organization spent $ 163 million in 2017 to implement these initiatives.

Still a difficult war

Antibiotic resistance is when bacteria and fungi stop responding to the drugs that are invented to destroy them.

It is an important health problem because even minor infections can be fatal if resistance occurs.

Although the CDC's efforts are significant, it is still a difficult battle for researchers to resist antibiotic-resistant bacteria and fungi.

Dr. Charles McKenna, professor of chemistry and pharmaceutical sciences at the University of Southern California (USC) said: "The efforts they are making are really commendable, but I don't think that it is the core solution of the problem, "he said.

"The core of our problem today, is gradually running out of effective drugs to kill pathogens," Dr. McKenna said.

Dr. McKenna said that CDC's reactions and diagnostic factors are essential, but the fight against antibiotic resistance is a better drug.

To deal with antibiotic resistance, we need to race against time.

"A microorganism like fungus or bacteria has the ability to develop a new resistance line quite quickly through the selection process." Dr. McKenna said.

"We will take a lot of time to research and invent a new drug, then the new drug must also pass the authorities' approval processes after clinical trials, before So, frankly speaking, bacteria are having a huge advantage over us. "

There is no specific method that can solve all problems. Different organisms react to different drugs. These organisms may also exhibit different levels of antibiotic resistance.

In some cases, one type of bacterium may become resistant to all drugs and there is only one drug left to kill the bacterium. Dr McKenna said: "If that drug becomes resistant, doctors will have to give up and accept to see that their patients die slowly without any treatment."

Different organisms react to different drugs.(Illustration).

The fight against drug resistance

Dr. McKenna is an expert on resistant mushrooms. He and a team of international researchers have recently discovered a new approach to dealing with Candida albicans, a potentially deadly antibiotic fungal strain.

His work is especially important because resistant fungi such as Candida albicans and Candida auris have been noticed and warned by medical organizations.

Candida auris, first discovered in Japan in 2009, was considered an emerging threat by its multi-drug resistance. In some cases, this fungus also shows resistance to all three major antifungals - so it is considered untreatable.

Patients infected with resistant fungi also often have high mortality rates. Although information is still limited, the estimated number is about 60%.

However, most of these infections and deaths occur in hospitals and in immunocompromised people. Pediatric patients and cancer patients who use immunosuppressants are particularly at risk.

If the disinfection rules are not correct, resistant fungi and other bacteria are able to live long in the hospital for weeks. For inpatients in hospitals with weakened immune systems, the risk is inevitable.

Drug resistance occurs when prescribing antibiotics indiscriminately.(Illustration).

What can you do now?

From a public health perspective, it seems that very few individuals can do anything to prevent antibiotic resistance, except for using less and more cautious antibiotics.

Dr McKenna said: "Drug resistance occurs when prescribing antibiotics indiscriminately, even for patients who take antibiotics even if they only have simple illnesses or those that are not caused by germs. mushroom".

"Sometimes doctors will prescribe antibiotics that are only used for prevention, but every time you do that, the doctors will facilitate the bacteria strains to develop resistance."

Dr. Craig said: "You should ask questions and ask for advice carefully before receiving medical care". "You should also ask about the risk of infection; which vaccines need to be given; and is the antibiotic the best treatment? And you should not force your doctor to prescribe antibiotics. if not needed ".